Paragon Wealth Strategies’s Pfizer PFE Stock Holding History

Paragon Wealth Strategies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-54	Closed	-$2.75K	–	176
2022 Q4	$2.75K	Buy	54 +1	+2%	+$48	﹤0.01%	178
2022 Q3	$2K	Buy	+53	New	+$2.58K	﹤0.01%	153
2021 Q3	–	Sell	-121	Closed	-$5K	–	215
2021 Q2	$5K	Buy	+121	New	+$4.71K	﹤0.01%	229
2019 Q4	–	Sell	-13,151	Closed	-$448K	–	49
2019 Q3	$448K	Buy	13,151 +3,547	+37%	+$129K	0.24%	33
2019 Q2	$395K	Buy	9,604 +4,547	+90%	+$181K	0.21%	31
2019 Q1	$204K	Buy	+5,057	New	+$203K	0.12%	47

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Paragon Wealth Strategies's PFE Position: Q1 2023 in Review

Paragon Wealth Strategies sold out of Pfizer (PFE) in Q1 2023, closing a stake of 54 shares — an estimated $2.75K sold.

Paragon Wealth Strategies first reported a position in PFE in Q1 2019 and held it in 6 quarters. The position peaked at $448K in Q3 2019. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Paragon Wealth Strategies reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Paragon Wealth Strategies sold 54 Pfizer shares in Q1 2023, an estimated $2.75K.
Paragon Wealth Strategies first reported a position in Pfizer in Q1 2019 and held it in 6 quarters.
Paragon Wealth Strategies's Pfizer position peaked at $448K in Q3 2019.
3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Paragon Wealth Strategies's 13F filing for Q1 2023, filed 26 Apr 2023.